Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection

Owens, Jr., Robert C., Donskey, Curtis J., Gaynes, Robert P., Loo, Vivian G., Muto, Carlene A.·2008·Clinical Infectious Diseases

Cited by (603)

Items 201–300 of 603

  1. Bacterial counts from five over-the-counter probiotics: Are you getting what you paid for?
    Ellie J. C. Goldstein, Diane M. Citron, Marina C. Claros, Kerin L. Tyrrell · 2013 · Anaerobe
  2. Trends in Clostridium difficile Infection among Peripartum Women
    Jennifer L. Kuntz, Ming Yang, Joseph E. Cavanaugh, Audrey F. Saftlas, Philip M. Polgreen · 2010 · Infection Control and Hospital Epidemiology
  3. Antimicrobial susceptibility of Clostridium difficile isolated from food animals on farms
    Sutawee N. Thitaram, Joseph F. Frank, Gregory R. Siragusa, J. STAN BAILEY, David A. Dargatz, Jason E. Lombard, Charles Haley, Steven A. Lyon, Paula J. Fedorka–Cray · 2016 · International Journal of Food Microbiology
  4. Macrolides, Clindamycin, and Ketolides
    Sumathi Sivapalasingam, Neal H. Steigbigel · 2015 · Elsevier eBooks
  5. The Impact of Antibiotic Stewardship Programs in Combating Quinolone Resistance: A Systematic Review and Recommendations for More Efficient Interventions
    Vasiliki Pitiriga, Georgia Vrioni, George Saroglou, Athanasios Tsakris · 2017 · Advances in Therapy
  6. Antibiotics Associated With Clostridium difficile Infection
    Abdur Rafey, Shah Jahan, Umer Farooq, Furqana Akhtar, Memoona Irshad, Summiya Nizamuddin, Azra Parveen · 2023 · Cureus
  7. A Clostridium difficile Lineage Endemic to Costa Rican Hospitals Is Multidrug Resistant by Acquisition of Chromosomal Mutations and Novel Mobile Genetic Elements
    Gabriel Ramírez-Vargas, Carlos Quesada-Gómez, Luis Acuña-Amador, Diana López‐Ureña, Tatiana Murillo, María del Mar Gamboa-Coronado, Esteban Chaves‐Olarte, Nicholas Robert Thomson, Evelyn Rodríguez-Cavallini, César Rodríguez · 2017 · Antimicrobial Agents and Chemotherapy
  8. Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics
    Cornelis H. van Werkhoven, J. van der Tempel, Rana Jajou, Steven F. T. Thijsen, Rob J. A. Diepersloot, Marc J. M. Bonten, Douwe F. Postma, Jan Jelrik Oosterheert · 2015 · Clinical Microbiology and Infection
  9. Polymerase chain reaction ribotyping of Clostridium difficileisolates in Qatar: a hospital-based study
    Asma Althani, Wedad S. Hamdi, Naser A Al-Ansari, Sanjay H. Doiphode · 2014 · BMC Infectious Diseases
  10. Safety Analysis of Fidaxomicin in Comparison With Oral Vancomycin for Clostridium difficile Infections
    Karl Weiss, Robin L. Allgren, S. Sellers · 2012 · Clinical Infectious Diseases
  11. An overview of harms associated with β-lactam antimicrobials: where do the carbapenems fit in?
    Robert C. Owens · 2008 · Critical Care
  12. Pitfalls in Diagnosis of Pediatric Clostridium difficile Infection
    Julia Shaklee Sammons, Philip Toltzis · 2015 · Infectious Disease Clinics of North America
  13. Racial Differences in Clostridium difficile Infection Rates Are Attributable to Disparities in Health Care Access
    Eric J. Mao, Colleen R. Kelly, Jason T. Machan · 2015 · Antimicrobial Agents and Chemotherapy
  14. Antimicrobial resistance in Clostridium difficile ribotype 017
    Korakrit Imwattana, Daniel R. Knight, Brian Kullin, Deirdre A. Collins, Papanin Putsathit, Pattarachai Kiratisin, Thomas Victor Riley · 2019 · Expert Review of Anti-infective Therapy
  15. Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study
    Brittany Stephenson, Cristina Lanzas, Suzanne Lenhart, Eduardo Cesar Lazcano-Ponce, Jason Bintz, Erik R. Dubberke, Judy Day · 2020 · BMC Infectious Diseases
  16. Recent trends in the epidemiology and treatment of C. difficile infection in children
    Julia Shaklee Sammons, Philip Toltzis · 2012 · Current Opinion in Pediatrics
  17. Recent development and fighting strategies for lincosamide antibiotic resistance
    Yingying Yang, Shiyu Xie, Fang-Jing He, Yindi Xu, Zhifang Wang, Awais Ihsan, Xu Wang · 2024 · Clinical Microbiology Reviews
  18. A Review of the Economics of Treating Clostridium difficile Infection
    Kari A. Mergenhagen, Amy L. Wojciechowski, Joseph A. Paladino · 2014 · PharmacoEconomics
  19. Clostridium difficile Infection
    Christopher L. Knight, Christina M. Surawicz · 2013 · Medical Clinics of North America
  20. Attitudes and beliefs of Australian emergency department clinicians on antimicrobial stewardship in the emergency department: A qualitative study
    Anne Goulopoulos, Olivia Rofe, David C. M. Kong, Andrew V Maclean, Mary O’Reilly · 2019 · Emergency Medicine Australasia
  21. Combined administration of antibiotics increases the incidence of antibiotic-associated diarrhea in critically ill patients
    Hongye Ma, Lei Zhang, Yanshu Zhang, Yu Liu, Yingli He, Litao Guo · 2019 · Infection and Drug Resistance
  22. Risk factors for Clostridioides difficile infection in children: a systematic review and meta-analysis
    N. Dong, Zhirong Li, Pu Qin, Cuixin Qiang, Jing Yang, Yanan Niu, X.R. Niu, Xiaoping Liu, W.G. Wang, Brian Wen et al. · 2022 · Journal of Hospital Infection
  23. The Emergence ofClostridium difficileInfection among Peripartum Women: A Case-Control Study of aC. difficileOutbreak on an Obstetrical Service
    Jennifer Beth Unger, Estella E. Whimbey, Michael G. Gravett, David A. Eschenbach · 2011 · Infectious Diseases in Obstetrics and Gynecology
  24. Effect of Ceftobiprole Treatment on Growth of and Toxin Production by Clostridium difficile in Cecal Contents of Mice
    Michelle M. Nerandzic, Curtis J. Donskey · 2011 · Antimicrobial Agents and Chemotherapy
  25. Risk Factors for Antibiotic-Associated Diarrhea in Critically Ill Patients
    Guo Litao, Jingjing Sun, Yu Liu, Zhang Lei, Xiaona He, Zhu Zhijing · 2018 · Medical Science Monitor
  26. Hospital management of Clostridium difficile infection: a review of the literature
    Nagham Léa Khanafer, Nicolas Voirin, Frédéric Barbut, Ed J. Kuijper, Philippe Vanhems · 2015 · Journal of Hospital Infection
  27. Clostridium difficile infections among adults and children in Mwanza/Tanzania: is it an underappreciated pathogen among immunocompromised patients in sub-Saharan Africa?
    Mwanaisha Seugendo, Stephen Eliatosha Mshana, Adolfine Hokororo, Bernard C. Okamo, Mariam M. Mirambo, Lutz von Müller, Katrin Gunka, Ortrud Zimmermann, Uwe Groß · 2015 · New Microbes and New Infections
  28. Dentists, antibiotics and Clostridium difficile-associated disease
    Nicholas Beacher, M. Petrina Sweeney, J. Bagg · 2015 · BDJ
  29. Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship Efforts
    Jennifer L. Kuntz, David H. Smith, Amanda F. Petrik, Xiuhai Yang, Micah L. Thorp, T L Barton, Karen Barton, Matthew J. Labreche, Steven J. Spindel, Eric S. Johnson · 2015 · The Permanente Journal
  30. Molecular epidemiology of Clostridium difficile infection in a Brazilian cancer hospital
    Cecília Leite Costa, Cibele Barreto Mano de Carvalho, Rafael Holanda González, Markus Andret Cavalcante Gifoni, Ronaldo de Albuquerque Ribeiro, Carlos Quesada-Gómez, Gerly Anne de Castro Brito · 2017 · Anaerobe
  31. Epidemiology of Community-Onset Staphylococcus aureus Bacteremia
    James Yarovoy, Andrew A. Monte, Bryan C. Knepper, Heather L. Young · 2019 · Western Journal of Emergency Medicine
  32. Impact of Antibiotic Treatment on the Gut Microbiome and its Resistome in Hematopoietic Stem Cell Transplant Recipients
    Jens Christian Nørgaard, Mette Jørgensen, Kasper Sommerlund Moestrup, Emma Elizabeth Ilett, Adrian G. Zucco, Ramtin Zargari Marandi, Marc Noguera-Julián, Roger Paredes, Jens Dilling Lundgren, Henrik Sengeløv et al. · 2023 · The Journal of Infectious Diseases
  33. The Cost–Benefit of Federal Investment in Preventing Clostridium difficile Infections through the Use of a Multifaceted Infection Control and Antimicrobial Stewardship Program
    Rachel B. Slayton, R. Douglas Scott, James M. Baggs, Fernanda C. Lessa, L. Clifford McDonald, John A. Jernigan · 2015 · Infection Control and Hospital Epidemiology
  34. The management of Clostridium difficile infection
    O. Martin Williams, R.C. Spencer · 2009 · British Medical Bulletin
  35. Antibiotics and antibiotic-associated diarrhea: a real-world disproportionality study of the FDA adverse event reporting system from 2004 to 2022
    Haining Huang, Lanfang Li, Mingli Wu, Zhen Liu, Yanyan Zhao, Jing Peng, Xiaolei Ren, Shuai Chen · 2023 · BMC Pharmacology and Toxicology
  36. Identification of Risk Factors for the Development of Clostridium difficile-Associated Diarrhea Following Treatment of Polymicrobial Surgical Infections
    Rosemarie Metzger, Brian R. Swenson, Hugo Bonatti, Traci L. Hedrick, Tjasa Hranjec, Kimberley A. Popovsky, Timothy L. Pruett, Robert Grant Sawyer · 2010 · Annals of Surgery
  37. What is the role of antimicrobial resistance in the new epidemic of Clostridium difficile?
    John Eugenio Coia · 2009 · International Journal of Antimicrobial Agents
  38. The Ecology of Antibiotic Use in the ICU: Homogeneous Prescribing of Cefepime but Not Tazocin Selects for Antibiotic Resistant Infection
    Andrew N. Ginn, Agnieszka M. Wiklendt, Heather F. Gidding, Narelle George, James S. O’Driscoll, Sally R. Partridge, Brian Ignatius O’Toole, Rita A. Perri, Joan Faoagali, John E. Gallagher et al. · 2012 · PLoS ONE
  39. Who Can Have Parenteral Antibiotics at Home?
    Laila F Ibrahim, Sandy M Hopper, Franz E Babl, Penelope Ann Bryant · 2015 · The Pediatric Infectious Disease Journal
  40. Attributable Cost ofClostridium difficileInfection in Pediatric Patients
    Preeti Mehrotra, Jisun Jang, Courtney A. Gidengil, Thomas J. Sandora · 2017 · Infection Control and Hospital Epidemiology
  41. Clostridium difficile: Epidemiology, Pathogenicity, and an Update on the Limitations of and Challenges in Its Diagnosis
    Abdullah A. Alyousef · 2017 · Journal of AOAC International
  42. Hospital-Wide Surveillance of Healthcare-Associated Infections as a Source of Information about Specific Hospital Needs. A 5-Year Observation in a Multiprofile Provincial Hospital in the South of Poland
    Małgorzata Kołpa, Marta Zofia Wałaszek, Anna Różańska, Zdzisław Wolak, Jadwiga Wójkowska‐Mach · 2018 · International Journal of Environmental Research and Public Health
  43. Evaluating contemporary antibiotics as a risk factor for Clostridium difficile infection in surgical trauma patients
    Kruti D. Shah, Leigh Ann Pass, Mark Cox, Matthew Lanham, Forest Wayne Arnold · 2012 · The Journal of Trauma: Injury, Infection, and Critical Care
  44. The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence
    Nele Moreels, Annelies Boven, Oswaldo Gressani, Fredrik Andersson, Erika Vlieghe, Steven F. J. Callens, Lars G. Engstrand, Johanna Simin, Nele Brusselaers · 2024 · Journal of Antimicrobial Chemotherapy
  45. Surveillance of Antibiotic Resistance among Hospital- and Community-Acquired Toxigenic Clostridium difficile Isolates over 5-Year Period in Kuwait
    Wafaa Y. Jamal, Vincent Olubunmi Rotimi · 2016 · PLoS ONE
  46. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China
    Chunhui Li, Juping Duan, Sidi Liu, Xiujuan Meng, Chenchao Fu, Cui Zeng, Anhua Wu · 2017 · Infection
  47. Microbiota-based approaches to mitigate infectious complications of intensive chemotherapy in patients with acute leukemia
    Armin Rashidi, Daniel Jordan Weisdorf · 2020 · Translational research
  48. Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain
    Danielle Secco, Ilana Teruszkin Balassiano, Renata Ferreira Boente, Karla Rodrigues Miranda, Jon Brazier, Val Hall, Joaquim dos Santos-Filho, Leandro Araújo Lobo, Simone Aranha Nouér, Regina Maria Cavalcanti Pilotto Domingues · 2014 · Anaerobe
  49. Octahedron Iron Oxide Nanocrystals Prohibited Clostridium difficile Spore Germination and Attenuated Local and Systemic Inflammation
    Wei‐Ting Lee, Ya‐Na Wu, Yi‐Hsuan Chen, Shang-Rung Wu, Tsai-Miao Shih, Tsung‐Ju Li, Li‐Xing Yang, Chen‐Sheng Yeh, Pei-Jane Tsai, Dar-Bin Shieh · 2017 · Scientific Reports
  50. Surveillance of antibiotic resistance among common Clostridium difficile ribotypes in Hong Kong
    Viola Chi Ying Chow, Thomas N.Y. Kwong, Erica W. M. So, Yolanda I. I. Ho, Sunny Hei Wong, Raymond W.M. Lai, Raphael C.Y. Chan · 2017 · Scientific Reports
  51. Incidence, Risk Factors, and Outcomes of Clostridium difficile Infections in Kidney Transplant Recipients
    Li G, Justin Trac, Shahid Husain, Olusegun Famure, Yanhong Li, Sang Joseph Kim · 2018 · Transplantation
  52. Clinical cure with ceftriaxone versus ceftaroline or ceftobiprole in the treatment of staphylococcal pneumonia: a systematic review and meta-analysis
    Khalid Eljaaly, Haytham Wali, Ahmed Basilim, Aisha A. Alharbi, Hani Z. Asfour · 2019 · International Journal of Antimicrobial Agents
  53. The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients
    Eavan Gabrielle Muldoon, Lauren H. Epstein, Tanya Logvinenko, Susan Murray, Shira Doron, David R. Snydman · 2013 · Anaerobe
  54. Gut microbiota patterns associated with somatostatin in patients undergoing pancreaticoduodenectomy: a prospective study
    Guanqun Li, Tao Zhang, Wei-Guang Yang, Hao-Liang Zhong, Peng Xiao, Liwei Liu, Yongwei Wang, Hua Chen, Rui Kong, Gang Wang et al. · 2020 · Cell Death Discovery
  55. Comparative effectiveness of macrolides and quinolones for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
    Michael B. Rothberg, Penelope S. Pekow, Maureen Lahti, Oren Brody, Daniel J. Skiest, Peter K. Lindenauer · 2010 · Journal of Hospital Medicine
  56. A selective antibiotic prophylaxis policy for laparoscopic cholecystectomy is effective in minimising infective complications
    Fady Yanni, Peter Mekhail, Gareth Morris‐Stiff · 2013 · Annals of The Royal College of Surgeons of England
  57. The characteristics of Clostridium difficile ST81, a new PCR ribotype of toxin A- B+ strain with high-level fluoroquinolones resistance and higher sporulation ability than ST37/PCR ribotype 017
    Baoya Wang, Wenwen Peng, Pingping Zhang, Jianrong Su · 2018 · FEMS Microbiology Letters
  58. Genetic and pharmacological inactivation of d-alanylation of teichoic acids sensitizes pathogenic enterococci to β-lactams
    Delphine Coupri, Aurélie Budin‐Verneuil, Axel Hartke, Abdellah Benachour, L Léger, Thierry P. Lequeux, Emmanuel Pfund, Nicolas Verneuil · 2019 · Journal of Antimicrobial Chemotherapy
  59. Healthcare-associated infections and antimicrobial use in long term care facilities (HALT-2)
    Claudia Ruscher, Martina Kraus-Haas, A. Nassauer, Martin E. A. Mielke · 2015 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  60. Non-conventional antimicrobial and alternative therapies for the treatment of Clostridium difficile infection
    Niloufar Roshan, Katherine A. Hammer, Thomas Victor Riley · 2018 · Anaerobe
  61. Clostridium difficile and fluoroquinolones: is there a link?
    Karl Weiss · 2009 · International Journal of Antimicrobial Agents
  62. Variation in Risk of Hospital-Onset Clostridium difficile Infection Across -Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia
    Brian T. Fisher, Julia Shaklee Sammons, Yichen Li, Peter M K de Blank, Alix Eden Seif, Yung-Sung Huang, Marko Kavčič, Sarah B. Klieger, T. Harris, Kari Torp et al. · 2014 · Journal of the Pediatric Infectious Diseases Society
  63. Epidemiología de la infección por Clostridium difficile en España
    Ángel Asensio, Diana Monge Martín · 2011 · Enfermedades Infecciosas y Microbiología Clínica
  64. Host response to Clostridium difficile infection: Diagnostics and detection
    Elena A. Usacheva, Jian‐Ping Jin, Lance R. Peterson · 2016 · Journal of Global Antimicrobial Resistance
  65. Insights into drug resistance mechanisms in Clostridium difficile
    Phurt Harnvoravongchai, Methinee Pipatthana, Surang Chankhamhaengdecha, Tavan Janvilisri · 2017 · Essays in Biochemistry
  66. A Retrospective Surveillance of the Antibiotics Prophylactic Use of Surgical Procedures in Private Hospitals in Indonesia
    Fauna Herawati, Rika Yulia, Eelko Hak, Adriaan H. Hartono, Timo Michiels, Herman J. Woerdenbag, Christina Avanti · 2018 · Hospital Pharmacy
  67. Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea
    José M. Brum, Roger Gibb, David L. Ramsey, Guhan Balan, Bruce Yacyshyn · 2020 · Digestive Diseases and Sciences
  68. Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials
    Moritz Mirna, Albert Topf, Lukas Schmutzler, Uta Charlotte Hoppe, Michael Lichtenauer · 2021 · Clinical Research in Cardiology
  69. Prevention and treatment of Clostridium difficile infection
    Theodore Gouliouris, Nicholas M Brown, Sani Hussein Aliyu · 2011 · Clinical Medicine
  70. Antimicrobial Stewardship and Clostridium difficile –Associated Diarrhea
    Frank J. Piacenti, Kimberly D. Leuthner · 2013 · Journal of Pharmacy Practice
  71. Multicentre derivation and validation of a simple predictive index for healthcare-associated Clostridium difficile infection
    M.L. Davis, Harlan G. Sparrow, Judy O. Ikwuagwu, William L. Musick, Kevin W. Garey, K.K. Perez · 2018 · Clinical Microbiology and Infection
  72. Emerging drugs for bacterial urinary tract infections
    Florian Wagenlehner, W. Weidner, Gianpaolo Perletti, Kurt G. Naber · 2010 · Expert Opinion on Emerging Drugs
  73. A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and Clostridioides difficile Infection
    Bogdan Ioan Vintilă, Anca Maria Arseniu, Claudiu Morgovan, Anca Butucă, Victoria Bîrluțiu, Carmen Maximiliana Dobrea, Luca Liviu Rus, Stéliana Ghibu, Alina Simona Bereanu, Rares Arseniu et al. · 2024 · Antibiotics
  74. The Management of Acne Vulgaris in Pregnancy
    Fiona M. Meredith, Anthony David Ormerod · 2013 · American Journal of Clinical Dermatology
  75. Susceptibilities of clinical Clostridium difficile isolates to antimicrobials: a systematic review and meta-analysis of studies since 1970
    Nagham Léa Khanafer, Nick Daneman, Tom Greene, Andrew E. Simor, Philippe Vanhems, Matthew H. Samore, Kevin Antoine Brown · 2017 · Clinical Microbiology and Infection
  76. Prevalence, genotype and antimicrobial resistance of Clostridium difficile isolates from healthy pets in Eastern China
    Yanxia Wei, Mingchuang Sun, Yuhan Zhang, Jing Xing Gao, Fanyun Kong, Dianbin Liu, Hao Yu, Jinxin Du, Renxian Tang · 2019 · BMC Infectious Diseases
  77. The Relationship between Inpatient Fluoroquinolone Use and Clostridium difficile-Associated Diarrhea
    Marilyn J Novell, Carol A. Morreale · 2010 · Annals of Pharmacotherapy
  78. Antimicrobial stewardship and pre-registration student nurses: Evaluation of teaching
    J. McEwen, Emma Burnett · 2017 · Journal of Infection Prevention
  79. Preventing infection in elders with long-term indwelling urinary catheters
    Linda Muzzi-Bjornson, Liz Macera · 2011 · Journal of the American Academy of Nurse Practitioners
  80. Reduction in the incidence of hospital-acquired Clostridium difficile infection through infection control interventions other than the restriction of antimicrobial use
    Eunsung You, Hyo-Yeop Song, Ji‐Hyun Cho, Jaehoon Lee · 2014 · International Journal of Infectious Diseases
  81. Impact of cleaning and other interventions on the reduction of hospital-acquired Clostridium difficile infections in two hospitals in England assessed using a breakpoint model
    G.J. Hughes, Emma K. Nickerson, David Enoch, J. S. Ahluwalia, C. Wilkinson, R. Ayers, Nicholas M. Brown · 2013 · Journal of Hospital Infection
  82. Performance evaluation of the Verigene® Clostridium difficile nucleic acid test, an automated multiplex molecular testing system for detection of C. difficile toxin
    Kosuke Kosai, Yuki Iwanaga, Norihiko Akamatsu, Yuya Okada, Norihito Kaku, Naoki Uno, Yoshitomo Morinaga, Hiroo Hasegawa, Taiga Miyazaki, Koichi Izumikawa et al. · 2017 · Journal of Infection and Chemotherapy
  83. Evolving concepts in Clostridium difficile colitis
    Naomi G. Diggs, Christina M. Surawicz · 2009 · Current Gastroenterology Reports
  84. Hematologic diseases: High risk ofClostridium difficileassociated diarrhea
    Tae‐Geun Gweon · 2014 · World Journal of Gastroenterology
  85. Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study
    António Ramos, Juan Manuel Pericàs, Ana Fernández‐Cruz, Patricia Muñóz, Maricela Valerio, Martha Kestler, Miguel Montejo, María Carmen Fariñas, Dolores Sousa, Fernándo Domínguez et al. · 2020 · PLoS ONE
  86. Differences in antibiotic and antiviral use in people with confirmed influenza: a retrospective comparison of rapid influenza PCR and multiplex respiratory virus PCR tests
    Victor Au Yeung, Kiran Thapa, William D. Rawlinson, Andrew Georgiou, Jeffrey John Post, Kristen Overton · 2021 · BMC Infectious Diseases
  87. Integral membrane pyrophosphatases: a novel drug target for human pathogens?
    Nita R. Shah, Keni Vidilaseris, Henri Xhaard, Adrian Goldman · 2016 · AIMS Biophysics
  88. Prophylactic Antibiotics for Upper Gastrointestinal Bleeding in Patients With Cirrhosis
    Connor J. Prosty, Constantinos Dean Noutsios, Laurie-Rose Dubé, Rachel P. Baden, Kusha Davar, Sarah Freling, Taft P. Bhuket, Hal F. Yee, Brad J. Spellberg, Emily Gibson McDonald et al. · 2025 · JAMA Internal Medicine
  89. Eravacycline, a novel tetracycline derivative, does not induceClostridioides difficileinfection in anin vitrohuman gut model
    Anthony M. Buckley, James Altringham, Emma Clark, Karen Bently, William D. Spittal, Duncan J. Ewin, Vikki Wilkinson, Georgina L. Davis, Inês Barata Moura, Mark H. Wilcox · 2020 · Journal of Antimicrobial Chemotherapy
  90. Impact of an antibiotic stewardship programme in a surgical setting
    Muhammad A. Bashar, Jacqui Miot, Evan Shoul, Robyn L. van Zyl · 2021 · Southern African Journal of Infectious Diseases
  91. ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis—study protocol for an interventional randomised controlled trial
    Dominic Crocombe, Norin Ahmed, Indran Balakrishnan, Ekaterina Bordea, Marisa Chau, Louise China, Lynsey Corless, Victoria Danquah, Hakim‐Moulay Dehbi, John Francis Dillon et al. · 2022 · Trials
  92. Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review
    Mayan Gilboa, Nadav Baharav, Eyal Melzer, Gili Regev‐Yochay, Dafna Yahav · 2023 · Infectious Diseases and Therapy
  93. Clostridium difficile infection in patients hospitalized with type 2 diabetes mellitus and its impact on morbidity, mortality, and the costs of inpatient care
    Titilope O. Olanipekun, Jason L. Salemi, Maria C. Mejia de Grubb, Sandra J. Gonzalez, Roger Zoorob · 2016 · Diabetes Research and Clinical Practice
  94. Screening of Natural Products and Approved Oncology Drug Libraries for Activity against Clostridioides difficile
    Rusha Pal, Mohamed N. Seleem · 2020 · Scientific Reports
  95. Enzyme Inhibitor Antibiotics and Antibiotic-Associated Diarrhea in Critically Ill Patients
    Yanshu Zhang, Jingjing Sun, Jing Zhang, Yu Liu, Litao Guo · 2018 · Medical Science Monitor
  96. Treatment of pediatric Clostridium difficile infection: a review on treatment efficacy and economic value
    Amanda D'Ostroph, Tsz-Yin So · 2017 · Infection and Drug Resistance
  97. Immunomodulatory tetracyclines ameliorate DNBS-colitis: Impact on microRNA expression and microbiota composition
    José Garrido‐Mesa, Francesca Algieri, Alba Rodríguez‐Nogales, Teresa Vezza, M. Pilar Utrilla, Féderico García, Natalia Chueca, Maria Elena Rodríguez‐Cabezas, Natividad Garrido‐Mesa, Júlio Gálvez · 2018 · Biochemical Pharmacology
  98. Epidemiological investigation of Clostridioides difficile colonization in Chinese community infants
    Qing-qing Cui, Jing Yang, Ya-nan Niu, Cuixin Qiang, Zhirong Li, Kaiyue Xu, Ru-xin Li, Dongyan Shi, Honglian Wei, Xingzhen Zhao et al. · 2019 · Anaerobe
  99. The Burden of Clostridium difficile after Cervical Spine Surgery
    Javier Z. Guzman, Branko Skovrlj, E Rothenberg, Young Lu, Steven J. McAnany, Samuel Kang-Wook Cho, Andrew C. Hecht, Sheeraz A. Qureshi · 2015 · Global Spine Journal
  100. The epidemiology ofClostridium difficileinfection in patients with cancer
    Andrew I.T. Hebbard, Monica A. Slavin, Caroline Reed, Benjamin W. Teh, Karin Thursky, Jason Anthony Trubiano, Leon James Worth · 2016 · Expert Review of Anti-infective Therapy